Biolife Solutions Stock Analysis
| BLFS Stock | USD 20.78 1.24 5.63% |
BioLife Solutions is undervalued with Real Value of 24.91 and Hype Value of 21.28. The main objective of BioLife Solutions stock analysis is to determine its intrinsic value, which is an estimate of what BioLife Solutions is worth, separate from its market price. There are two main types of BioLife Solutions' stock analysis: fundamental analysis and technical analysis.
The BioLife Solutions stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BioLife Solutions is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. BioLife Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. BioLife Stock Analysis Notes
About 97.0% of the company shares are held by institutions such as insurance companies. The book value of BioLife Solutions was currently reported as 7.42. The company has Price/Earnings (P/E) ratio of 173.59. BioLife Solutions recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. The firm had 1:14 split on the 29th of January 2014. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people. For more info on BioLife Solutions please contact Michael Rice at 425 402 1400 or go to https://www.biolifesolutions.com.BioLife Solutions Investment Alerts
| BioLife Solutions generated a negative expected return over the last 90 days | |
| BioLife Solutions has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 82.25 M. Net Loss for the year was (20.18 M) with profit before overhead, payroll, taxes, and interest of 57.22 M. | |
| BioLife Solutions has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies |
BioLife Solutions Upcoming and Recent Events
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
BioLife Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.05 B.BioLife Profitablity
The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05.Technical Drivers
As of the 16th of July 2025, BioLife Solutions shows the Risk Adjusted Performance of (0.01), mean deviation of 2.61, and Standard Deviation of 3.58. BioLife Solutions technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioLife Solutions variance and potential upside to decide if BioLife Solutions is priced correctly, providing market reflects its regular price of 20.78 per share. Given that BioLife Solutions has information ratio of (0.05), we suggest you to validate BioLife Solutions's prevailing market performance to make sure the company can sustain itself at a future point.BioLife Solutions Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioLife Solutions middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioLife Solutions. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioLife Solutions Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioLife Solutions insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioLife Solutions' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BioLife Solutions insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BioLife Solutions Outstanding Bonds
BioLife Solutions issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioLife Solutions uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioLife bonds can be classified according to their maturity, which is the date when BioLife Solutions has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
| BIOGEN INC Corp BondUS09062XAG88 | View | |
| BIOGEN INC Corp BondUS09062XAH61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| BIIB 325 15 FEB 51 Corp BondUS09062XAK90 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
BioLife Solutions Predictive Daily Indicators
BioLife Solutions intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioLife Solutions stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 34620.35 | |||
| Daily Balance Of Power | (0.71) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 21.56 | |||
| Day Typical Price | 21.3 | |||
| Price Action Indicator | (1.39) | |||
| Period Momentum Indicator | (1.24) | |||
| Relative Strength Index | 44.15 |
BioLife Solutions Forecast Models
BioLife Solutions' time-series forecasting models are one of many BioLife Solutions' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioLife Solutions' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioLife Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioLife Solutions prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioLife shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioLife Solutions. By using and applying BioLife Stock analysis, traders can create a robust methodology for identifying BioLife entry and exit points for their positions.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioLife Solutions to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.